Vol.
: 318
02 NOV,2016
Index
M AR K E T VI E W
Market View
Company Update
Around the
Economy
Knowledge Corner
3 0 . 1 % whi l e e m e r gi n g m ar ke t s r al l i e d 1 % i n t he m o nt h o f Se pt e m be r .
Mutual Fund
4 Lo c al m ar ke t de c l i ne d f o r t he f i rs t t i m e o n m o nt h t o m o nt h b as i s i n
Commodity Corner
Forex Corner
Report Card
7 w hi c h de ri ve r e ve nue s fr o m a br o ad . M e t al s a n d a ut o s e c t o r s ar e
Short Term Call Status
M AR K E T, TH E W O R LD O VE R AR E TAK I NG A B R E AK
Fr o m t he Se pt e m be r o n war ds , t he wo r l d m ar ke t i s t a ki ng a t i m e
o ut a n d go i ng no whe r e . M ar ke t s o f de ve l o pe d e c o no m i e s r al l i e d
Se pt e m be r af t e r s i x c o ns e c ut i ve m o nt hl y r i s e s .
U nde r t he c i r c um -
s t anc e s , i t i s i m po r t ant t o r e l o o k t he po r t f o l i o and c h ur n i t ac c o r di ngl y. Fo r e . g . do m e s t i c pur e pl ays o ut pe r fo r m t he c o m p ani e s
c l e ar e xam pl e o f t hi s s wi t c h f r o m e xpo r t l e ad c o m p a ni e s t o do m e s t ic
l e ad s t o r i e s . J SW St e e l , Hi n dal c o , Tat a St e e l , M ar ut i a nd Ei c he r ar e
Editor & Contributor
Darshana Mishra
go o d e xa m pl e s o f do m e s t i c pl ay. At t hi s po i nt o f t i m e it i s i m po r t ant
t o f i nd o ut c o m pani e s wi t h m o at . As B uf f e t t de s c r i be d, i n 1 7 t h and
Special Contributors
Kunal Shah
Dhaval Ghodasara
1 8 t h c e nt ur i e s a c as t l e ( ki l lo ) was b ui l t s ur r o un de d by de e p wat e r
an d f i l l e d wi t h l i ve ani m al s an d d an ge r o us i t e m s . Di ppe r an d wi de r
t he m o at i s , t he ki ng l i vi n g i ns i de t he c as t l e l i ve s s af e l y an d l o nge r
pe r i o d o f t i m e . Sam e wa y t he c o m p a ni e s ha vi ng c l e ar c o m pe t i t i ve
ad va nt a ge c a n s us t ai n t he pr o f i t abi l i t y f o r l o n ge r pe r i o d o f t i m e
Te c hni c al l y, t he m ar ke t i s r an ge d bo un d wi t h u p war d bi as a n d
For suggestions, feedback
and queries
jstreet@jhaveritrade.com
t he r e i s s t ro ng s up po r t i n t he r an ge o f 8 5 00 - 8 55 0 and s t r o ng r e s i s t anc e be t we e n 8 7 0 0 - 8 8 00 .
K a m a l J h a v e ri
M D- Jha ve ri S e curi ti e s
-1-
Vol.: 318
02 NOV,2016
Company Update : Alembic Pharmaceuticals Limited.
Company Basics
BSE Code
NSE Symbol
APLLTD
FV (`)
EPS (`) (TTM)
P/E (x) (TTM)
2.00
38.02
16.4
37.7
P/BV (x) (TTM)
7.3
533573
EQUITY (` in Cr.)
MKT.CAP (` in Cr.)
Financial Basics
11818
BETA
RONW (%)
0.7
57.9
Share Holding Pattern
Holder's Name
% Holding
Foreign
11.10
Institutions
3.5
Promoters
74.10
Non. Promoters
0.00
Public & Others
11.30
Outlook
and valuation : We expect revenues to post 4% CAGR growth over FY16-18E on a high base of FY16 with EBITDA
margins set to decline post robust planned R&D investments and elevated capex plan from a high of 32% in FY16 to 21% in
FY18E. At CMP of INR 627, the stock is trading at 21.5x FY18E EPS. We maintain our earnings estimates and rate the stock BUY valuing it (at a higher multiple given the enhanced potential of its pipeline) at 22x of FY18E EPS of INR 29.1 (earlier FY18E EPS of I NR
28.3), to arrive at a revised Target Price of 732 .
Company Overview :
Alembic Pharmaceuticals is a leading pharmaceutical company in India. The company is vertically integrated to develop pharmaceutical substances and intermediates. The company is a market leader in the
Macrolides segment of anti-infective drugs in India. Its manufacturing facilities are located in Vadodara and in
Baddi (Himachal Pradesh; for the domestic and non-regulated export market). The Panelav facility houses the
API and formulation manufacturing (both USFDA approved) plants.
Investment rational :
Focus on chronic segment to drive domestic formulation growth :
Alembic P harma has been restructuring its business portfolio, which would aid in improving its growth and operating performance. The companys domestic formulation business contributed 44% to its total sales in FY2016. The company has a
strong field force of ~3,600 medical representatives. Going forward, the company expects its domestic formulation business to at least grow in line with the industry growth rate, before it sees an improvement in the share of the high growth
chronic segment. For FY2016-18E, we expect the domestic formulation business to grow at a CAGR of 15.0%.
Exports- US the key growth driver:
On the exports front, the formulation business contributed by 30% to the total turnover, with majority of the contribution coming from Europe and the US. In the US, the company has filed for ~76 ANDAs till date and received
47 approvals. The company, going forward, expects to keep its momentum high in terms of number of filings,
by filing around 10-12 ANDAs per annum. For FY2016-18E, we expect exports to register a CAGR of 13.6%, mainly
on back of base effect impact of FY2016 (sales grew by 46% due to launch of Abilify).
Outlook and valuation :
Over FY2016-18E, we expect the company to post a CAGR of 13.9% in sales, while profitability will be under pressure
on back of higher R&D spend, which is likely to reach 13-14% of sales in FY2017-FY2018E. We recommend a Neutral rating
on the stock.
- 2-
Vol.: 318
02 NOV,2016
Around The World
Weekly Market Recap :
Trading for the week started on a positive note on Monday, 24 October 2016, as key benc hmark indices settled wit h small gains as firmness in global stocks boosted sentiment. Banking, metal and pharma sector stocks led modest losses for key benchmark indices on
Wednesday, 26 October 2016. DRL announced that it has entered into a strategic collaboration with Gland Pharma, to market and distribute a diverse portfolio of eight injectable Abbreviated New Drug Applications (ANDAs).
On the global front, data showed that the Markit flash US manufacturing purchasing managers' index rose to 53.2 in October fr om 51.5 in
September. Data showed that profit growth in China's industrial firms slowed in September from the previous month's rapid pace as several sectors showed weak activity, suggesting economy remains underpowered des pite emerging signs of stability.
Market Eye Week ahead :
Among macro economic data, Markit Economics will announce t he India Manufacturing Purchasing Managers' Index (PMI) data for O ctober 2016 on Tuesday, 1 November 2016. The seasonally adjusted Nikkei India Manufacturing PMI fell to 52.1 in September from 5 2.6 in
August. Markit Economics will announce the India Services PMI data for October 2016 on Thursday, 3 November 2016.
On the global front, US Federal Reserve's monetary policy statement is due on Wednesday, 2 November 2016. On Friday, 4 Novemb er
2016, the crucial US nonfarm payrolls data for the month of October is due. The Bank of Japan's monetary policy statement is due on
Tuesday, 1 November 2016. The Eurozone Q3 gross domestic product (GDP) will be released on Monday, 31 October 2016.
Key Events / Factors to Watch
1. Mon : Re sults: 2.
Tue : - Results: IDFC Ltd, Hindustan Media Ventures
3.
Wed : Results : HT Media, Sonata Software, Sundaram Fasteners
4.
Thu: Re sults: Ambuja Cements, Berger Paints, Shoppers stop, Whirlpool India.
5.
Fri : Results: Allahabad Bank, CBI Bank, CARE Ltd, Gati Ltd, Pfizer ltd.
Knowledge Corner :
Qualified institutional placement (QIP)
These Qualified institutional placement (QIP) is a capital-raising tool, primarily used in India and other parts of southern
Asia, whereby a listed company can issue equity shares, fully and partly convertible debentures, or any securities other
than warrants which are convertible to equity shares to a qualified institutional buyer (QIB).
How much can companies raise via QIP : In a single financial year a company can raise not more than 5 times its net
worth based on the audited financial statements of the previous financial year.
- 3-
Vol.: 318
02 NOV,2016
Mutual Fund Corner
Top 10 Sector Break-Ups
Fund Name
Scheme Name
Sector Weights
ICICI PRUDENTIAL VALUE DISCOVERY FUND
Fund (% )
Financial
Automobile
23.62
7.23
Equity-oriented
Energy
Healthcare
7.96
9.22
Category
Open-ended
Engineering
5.32
Launch Date
Feburary 2011
Technology
Services
13.01
5.61
Fund Manager
Mrinal Singh since Feb 2011
Construction
6.88
Diversified
5.55
Chemicals
2.36
AMC
ICICI Prudential Asset Management Company
Type
Net Assets
In crore )
History
NAV (Rs)
Total Return (%)
Rank (Fund/Category)
(`
Rs. 14460.6 crore as on Sep 30,2016
2013
2014
2015
62.15
107.99
113.86
126.86
8.31
73.76
5.44
11.42
9/47
25/78
37/187
119/155
52 W eek Hi gh (Rs)
62.15
108.70
120.07
128.60
52 Week Low (Rs)
47.85
58.56
106.67
97.50
Net Assets (Rs.Cr)
2830.81
7367.40
Expens e Ratio (%)
2.33
2.26
10664.05
2.24
Risk Analysis
2016
14044. 28
-
Volatility Measures
Standard Deviation
17.13
Sharpe Ratio
1.49
Beta
1.02
R-Squared
Alpha
0.78
15.62
Composition (% )
Equity
91.36
Debt
8.07
Cash
0.57
Fund Performance v/s S&P BSE 100
Fund Style
Investment Style
Growth
Blend
Value
Medium
Small
Fund
S&P BSE 100
(Rebased to 10,000)
- 4-
Capit alization
Large
Source : - www.valueresearchonline.com
Vol.: 318
02 NOV,2016
Commodity Corne r
BULLION
FUNDAMENTAL: Bullion
prices ended with gains on weekly basis where gold gained by 0.45% and silver by over one percent
gains as prices recovered on Friday in the evening session after the FBI said it will further investigate Democratic presidential candidate Hillary Clinton's use of a private email system. Gold demand in India spiked as festive buying lifted the premium over official domestic prices to its highest in 10 months, although buying else where in Asia remained tepid. Gold
prices in India, the world's second largest consumer, were at a premium of up to $3 an ounce over official domestic prices
this week, the highest in 2016 and against $2 the previous week, buoyed by purchases for the Dhanteras and Diwali festivals. India's overseas purchases of gold likely hit a nine-month high in October, as a flip in domestic prices to a premium
prompted banks and refiners to resume imports ahead of the festival season. Meanwhile, the world's largest consumer
China witnessed a slowdown in purchases, with buyers waiting for a further fall in gold prices as premiums slipped to $2
from $4- $5 against the international benchmark last week. The U.S. economy grew by 2.9 percent in the third quarter, outpacing consensus forecast of 2.5percent.
.
RECOMMENDATION : BUY GOLD @ 29950 SL 29700 TGT 30150-350 BUY SILVER @42250 SL 41750 TGT 42850-43350.
BASE METALS
Last week, base metals prices rallied buoyed by brightening prospects for the U.S. economy and by a rally
across China's steel sector that fuelled speculative buying in metals. New U.S. single-family home sales unexpectedly rose
in September, pointing to sustained demand for housing even as data for the prior three months was revised lower. Gains in
the week had been partly due to Chinese speculative activity, which had receded after China's Zhengzhou Commodity Exchange doubled the charges for intraday trading in thermal coal. Demand for base metals from China is likely to grow in
2017, according to Goldman Sachs, which revised up by 3 percent its copper price forecast for 2016. The bank now sees
copper averaging $4,693 per tonne in 2016 versus $4,565 expected previously. Also supporting copper prices are stocks in
LME-approved warehouses, which at 331,450 tonnes have fallen more than 12 percent since late September. Volatility is
picking up as traders square books ahead of an industry event in London. China accounts for nearly half of global copper
demand estimated at around 22 million tonnes this year. Chinese consumers are expected to import more over coming
months due to stronger local demand.
FUNDAMENTAL:
RECOMMENDATION : BUY ALUMINIUM @ 113 SL 110 TGT 115.8-117 BUY COPPER @ 324 SL 318 TGT 332-338 BUY ZINC @ 160 SL
154 TGT 168-174 BUY NICKEL @ 695 SL 680 TGT 710-725.
ENERGY
FUNDAMENTAL : Last
week, crude oil prices dropped on concerns OPEC will not fully carry out a planned output cut, even as
data showed U.S. oil drillers removed rigs from production for the first time since June. OPEC officials meeting in Vienna to
work out the details of their plan to reduce oil production failed to reach agreement after hours of talks on Friday, amid objections by Iran which has been reluctant to even freeze its output, OPEC sources said. The High Level Committee of experts will meet again in Vienna on Nov. 25 ahead of the next meeting of OPEC ministers on Nov. 30, to "finalise individual
quotas", source said. Oil prices have been under pressure in recent days amid market skepticism over the implementation
of a planned deal by OPEC to limit production. The 14-member oil group reached an agreement to cap output to a range of
32.5 million to 33.0 million barrels per day in talks held on the sidelines of an energy conference in Algeria late last month.
However, OPEC said it wont finalize details on individual output quotas until its next official meeting in Vienna on November
30.
RECOMMENDATION : SELL CRUDE @ 3220 SL 3350 TGT 3000. BUY NAT.GAS @ 206 SL 215 TGT 195.
- 5-
Vol.: 318
02 NOV ,2016
Commodity
Corne r
Forex Corner
Market Recap :
The Indian rupee weakened marginally against
the US dollar tracking the losses in the local equity markets.
Traders are cautious ahead of the Federal Reserves statement at the completion of its two-day
meeting on Wednesday and any new indication
that an interest rate hike is likely at the central
banks December meeting as the US holds its
presidential election on 8 November.
Market Eye Week ahead :
The USDINR On daily chart pair has formed DOJI candlestick pattern. Which represent uncertainty, and other
hand pair has been trading below all short term, medium term, and long term moving average which is 20, 100
and 200.Whereas on weekly chart pair has continually taking support at 50WMA. Which suggest short term trend
is bullish. So for trading perspective, one could buy up to the level 66.88-66.98 with SL of 66.70 for target of
67.03-67.50.
USD/INR
Level
S2
S1
CP
R1
R2
High
Low
Close
USD/INR
66.93
66.88
66.98
67.03
67.08
67.03
66.93
66.98
Level
S2
S1
CP
R1
R2
High
Low
Close
EUR/INR
73.52
73.30
73.65
73.87
74.00
73.77
73.42
73.75
Level
S2
S1
CP
R1
R2
High
Low
Close
GBP/INR
81.90
81.70
82.11
82.31
82.52
82.31
81.90
82.11
Level
S2
S1
CP
R1
R2
High
Low
Close
JPY/INR
63.74
63.62
63.86
63.98
63.62
63.98
63.74
63.86
EUR/INR
GBP/INR
JPY/INR
-- 46--
Vol.: 318
02 NOV,2016
J Street Recommendations Report Card
Nifty last week opened at 8709.85 and attained a high at 8736.95. A fall during the week to 8550.25 was witnessed and
the week closed at 8638 thereby showed a net fall of 0.63% on week to week basis. Traders short and still holding the
short position can maintain the stop loss at 8750. Traders long and holding the same can maintain the stop loss at
8500.Sideways movement for 3 week between 8750-8500 is being witnessed. Therefore, next direction movement is outside
the band of 8750-8500. Sell is below 8500 with high of the week as the stop loss or 8638 whichever is lower. Alternatively, buy
above 8750 with low of the week as the stop loss of 8638 whichever is lower.
Top Fundamental Stocks
Rec. Date
CMP on Rec.
CMP
Target
Absolute
Return @
CMP
30/08/2016
630
675
732
0%
Buy
25/07/2016
235
277
308
1%
Buy
Capital First
06/06/2016
552
766
660
8%
Profit book
Wonderla Holidays
25/04/2016
387
407
498
6%
Accumulate
Mold-Tek Packaging
04/04/2016
138
51
179
4%
Buy
Jamna Auto
22/02/2016
133
223
181
-2%
Buy
MT Educare
01/02/2016
164
136
230
2%
Buy
Garware-Wall Ropes
28/12/2015
425
528
550
-4%
Buy
AYM Syntax
23/11/2015
121
87
223
4%
Buy
Natco Parma
02/11/2015
509
596
636
1%
Buy
SRF
21/09/2015
1140
1908
1374
8%
Buy
Ahluwalia contracts
24/08/2015
235
292
368
2%
Buy
20/07/2015
190
235
255
-3%
Buy
04/05/2015
298
278
430
3%
Buy
16/03/2015
152
173
251
4%
Buy
DHFL
16/02/2015
252
331
368
4%
Accumulate
TV Today Network
27/01/2015
222
330
337
-4%
Buy
M&M
12/01/2015
1238
1327
1452
-2%
Buy
Havells India
27/10/2014
274
412
346
1%
Buy
PTC India Fin. Ser.
07/07/2014
39
39
45
-5%
Profit book
Adani Port
05/07/2014
280
285
347
-6%
Accumulate
Stocks
Alembic Pharmaceuticals
Coromandel
International
Infinite Computer
Sol.
Sadbhav
Engineering Ltd.
Omkar speciality
Chemicals
Status
It's not important whether you are right or wrong, Its about how much money you make when you're right and how
much you lose when you're wrong.
- 7-
Vol.: 318
02 NOV,2016
J Street Short Term Call Status
RANGE
RANGE
TRIGGER
PRICE
TGT
SL
STATUS
%
RETURN
800
816
808.00
851.00
780
SL
-3.50
BUY
1070
1080
1075.00 1020.00
1110
TA
4.60
STAR
BUY
990
1010
1000.00 1060.00
960
TA
5.80
15-Sep-16
UPL
BUY
695
700
697.50
730.00
675
EXPIRE
16-Sep-16
BRITTANIA
BUY
3510
3540
3525.00 3690.00
3390
EXPIRE
19-Sep-16
ITC
BUY
260
264
262.00
275.00
252
SL
-3.60
20-Sep-16
BIOCON
BUY
925
935
930.00
972.00
900
TA
4.50
21-Sep-16
HDFC
BUY
1385
1395
1390.00 1450.00
1355
EXPIRE
22-Sep-16
INFRATEL
BUY
370
375
372.50
391.00
358
OPEN
10
23-Sep-16
TVSMOTOR
BUY
347
353
350.00
367.00
337
TA
4.80
11
26-Sep-16
HDFC
BUY
1405
1435
1420.00 1492.00
1365
SL
-3.80
12
27-Sep-16
JUBLFOOD
SELL
960
950
955.00
912.00
985
TA
4.50
13
28-Sep-16
ITC
SELL
248
245
246.50
235.00
254
TA
4.40
14
29-Sep-16
TATAGLOBAL BUY
143
147
145.00
153.00
139
TA
5.50
15
3-Oct-16
BUY
1395
1415
1405.00 1476.00
1355
EXPIRE
16
4-Oct-16
MOTHERSUMI BUY
325
330
327.50
342.00
315
SL
-3.50
17
5-Oct-16
LICHSGFIN
BUY
596
606
601.00
624.00
576
TA
4.40
18
6-Oct-16
ASIANPAINT
BUY
1190
1210
1200.00 1258.00
1156
OPEN
19
7-Oct-16
TATASTEEL
BUY
402
410
406.00
429.00
386
TA
4.90
20
13-Oct-16
NTPC
SELL
148
146
147.00
140.00
152
SL
-3.80
21
14-Oct-16
BATAINDIA
SELL
498
492
495.00
480.00
509
TA
3.20
22
17-Oct-16
NBCC
SELL
257
255
256.00
245.00
265
TA
4.00
23
18-Oct-16
ZEEL
SELL
508
498
503.00
478.00
520
OPEN
Sr.
No.
DATE
9-Sep-16
12-Sep-16
JUBLFOOD
14-Sep-16
- 7-
STOCK
BUY/
SELL
SUNPHARMA BUY
M&M
Vol.: 318
02 NOV, 2016
J Street Short Term Call Status
Sr. No.
DATE
STOCK
BUY/
SELL
RANGE
RANGE
TRIGGER
PRICE
TGT
SL
STATUS
24
19-Oct-16
YESBANK
BUY
1285
1296
1290.50
1348.00
1249
OPEN
25
20-Oct-16
WIPRO
BUY
490
498
494.00
518.00
475
OPEN
26
21-Oct-16
HINDALCO
BUY
154
156
155.00
163.00
150
OPEN
27
24-Oct-16
IGL
BUY
856
870
863.00
904.00
834
OPEN
28
25-Oct-16
LUPIN
BUY
1515
1535
1525.00
1595.00
1468
OPEN
29
26-Oct-16
DRREDDY
BUY
3180
3220
3200.00
3348.00
3090
OPEN
30
27-Oct-16
BIOCON
SELL
915
900
907.50
864.00
940
OPEN
STATUS
CALLS
RATIO
TA+PB
11
68.75
SL+EXIT
05
31.25
TOTAL
16
100.00
%
RETURN
One call on daily basis is given keeping view of short term trading on closing basis.
Time frame and expected % of return is also mentioned with the suggested call.
This call are purely given on technical trading system generated by the Technical Research Desk.
Generally Expected Return on investment is 5-6 % with time horizon of 6-7 days.
Profit Booking update is considered if on an average expected return exceed 3.50-4.00 % against the
Expected return of 5-6%
Risk- Reward ratio percentage wise depends on the volatility of stock Normally it stands ( 3 : 9)
- 7-
Vol.: 318
02 NOV,2016